UY38413A - PLASMA DIALYSIS SYSTEMS - Google Patents

PLASMA DIALYSIS SYSTEMS

Info

Publication number
UY38413A
UY38413A UY0001038413A UY38413A UY38413A UY 38413 A UY38413 A UY 38413A UY 0001038413 A UY0001038413 A UY 0001038413A UY 38413 A UY38413 A UY 38413A UY 38413 A UY38413 A UY 38413A
Authority
UY
Uruguay
Prior art keywords
plasma
separated
devices
dialysis systems
plasma dialysis
Prior art date
Application number
UY0001038413A
Other languages
Spanish (es)
Inventor
Soo Park Sung
Bin Park Eun
Jae Park Eun
Mee Jyung Kyung
Original Assignee
Awesome Medical Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awesome Medical Company Llc filed Critical Awesome Medical Company Llc
Publication of UY38413A publication Critical patent/UY38413A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3479—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by dialysing the filtrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)

Abstract

La presente invención provee sistemas y dispositivo para diálisis renal en los que, se separa al menos una porción del plasma de la porción celular de sangre, y se dializa el plasma separado (en lugar de la sangre completa). En ciertas realizaciones, el plasma separado es ultrafiltrado de plasma. Comparado con la hemodiálisis, los aparatos y métodos provistos permiten que las toxinas como por ej., urea, creatinina y beta-2-microglobulina sean removidas más eficazmente, y tengan una mayor estabilidad hemodinámica y también se logran tasas menores de hemólisis.The present invention provides systems and devices for renal dialysis in which at least a portion of the plasma is separated from the cellular portion of blood, and the separated plasma (instead of whole blood) is dialyzed. In certain embodiments, the separated plasma is plasma ultrafiltered. Compared with hemodialysis, the devices and methods provided allow toxins such as urea, creatinine, and beta-2-microglobulin to be removed more efficiently, and to have higher hemodynamic stability and also lower rates of hemolysis are achieved.

UY0001038413A 2018-10-11 2019-10-11 PLASMA DIALYSIS SYSTEMS UY38413A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862744408P 2018-10-11 2018-10-11

Publications (1)

Publication Number Publication Date
UY38413A true UY38413A (en) 2020-05-29

Family

ID=68345066

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038413A UY38413A (en) 2018-10-11 2019-10-11 PLASMA DIALYSIS SYSTEMS

Country Status (4)

Country Link
AR (1) AR116917A1 (en)
TW (1) TW202042849A (en)
UY (1) UY38413A (en)
WO (1) WO2020076945A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11517653B2 (en) 2019-11-05 2022-12-06 Diality Inc. Hemodialysis system reservoir level sensor
WO2023150217A1 (en) * 2022-02-02 2023-08-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Restrictive versus liberal rate of extracorporeal volume removal evaluation in acute kidney injury
WO2024097706A1 (en) * 2022-11-02 2024-05-10 University Of Washington System for removing protein bound uremic toxins during hemodialysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151082A (en) * 1988-08-05 1992-09-29 Heathdyne, Inc. Apparatus and method for kidney dialysis using plasma in lieu of blood
US5976870A (en) 1994-11-09 1999-11-02 Park; Sung-Su Artificial liver composed of a liver-slice culture apparatus
KR0129833B1 (en) 1994-11-09 1998-04-04 박성수 Method of orgna culture and apparatus thereof
WO2001058496A1 (en) * 2000-02-11 2001-08-16 Allied Therapeutics Limited System for the extracorporeal treatment of blood
USD552740S1 (en) 2005-10-21 2007-10-09 Hepahope, Inc. Medical device for assisting liver function
US9713668B2 (en) * 2012-01-04 2017-07-25 Medtronic, Inc. Multi-staged filtration system for blood fluid removal
PL3412358T3 (en) 2014-02-06 2022-09-19 Gambro Lundia Ab Membrane for blood purification

Also Published As

Publication number Publication date
AR116917A1 (en) 2021-06-30
WO2020076945A1 (en) 2020-04-16
TW202042849A (en) 2020-12-01

Similar Documents

Publication Publication Date Title
UY38413A (en) PLASMA DIALYSIS SYSTEMS
CL2016002161A1 (en) A hemodialysis system comprising: an arterial bloodline; a venous blood line; a dialyzer; a blood flow path connected to said arterial blood line and said venous blood line; a deposit; a dialysate flow path; a filter connected to said flow dialysate flow path; a first bomb; a second pump; and a third pump each pump with a motor and actuator with a rotor positioned eccentrically within a cavity.
World Health Organization Violence against women
CO2020013252A2 (en) Subcutaneous dosage of anti-cd38 antibodies
CL2018000087A1 (en) Methods for manufacturing a silica reinforced elastomer compound and products containing it
GB2558838A (en) Acoustic wave filter with enhanced rejection
MX2021015165A (en) Methods of processing a fluid including a recombinant therapeutic protein and use thereof.
AR118921A2 (en) ABSORBENT CELLULOSIC SHEET
AR091977A1 (en) THE USE OF ANTITROMBIN IN OXYGENATION OF EXTRACORPORE MEMBRANES
MX2020004469A (en) Treating ige-mediated allergic diseases.
SE1651594A1 (en) Sulfonamide analogues of galiellalactone
DE112017002519A5 (en) System for extracorporeal membrane oxygenation with a blood pump and an oxygenator
BR112012031229A2 (en) "tunable resonator patch filter"
Morais et al. Adesão à terapia imunossupressora em receptores de transplante renal
CL2019003153A1 (en) Methods for the treatment of alport syndrome.
BR112019004829A2 (en) water processing system and associated methods
Xin Analysis of related risk factors of retinopathy in pregnancy induced hypertension syndrome
Lei et al. Effects of hemodialysis on immune function of patients with end-stage nephropathy associated HBV virus infection
Zhang et al. Alizarin induced the function of beta subunits of BKCa channel relaxed interlobar renal artery and reduced SHR systolic pressure
BU et al. The relationship between the prevalence of isolated systolic hypertension and the stages of chronic kidney disease in chronic kidney disease outpatient clinic
Ding et al. Experience of ApplyingHuoxue Tongfu Therapy in Ancillary Treatment of Severe Traumatic Brain Injury Combined with Pulmonary Contusion Syndrome
Oyetunde Timothy et al. Frequency of human immunodeficiency virus [HIV] in Trichomonas vaginalis infected women in Badagry, Lagos, Nigeria
Koz et al. Features of Hemodialysis in Cirrhotic Patients: Single Center Experience
Mohammed et al. Prevalence and risk factors of antenatal depression among Omani women in a primary care setting cross-sectional study
Ekpe et al. Human Immune-deficiency virus associated deep vein thrombosis coexisting with venous ulcer.

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20201203